Disruption in health services during COVID-19 pandemic threatens elimination of hepatitis in Latin America and the Caribbean 27 Jul 2021 Elimination of hepatitis B and C by 2030 is still an achievable goal, PAHO Director said, calling on countries to sustain hepatitis testing, prevention, vaccination, and treatment services while integrating them into primary health care. Washington, D.C., July 27, 2020 (PAHO) - A recent survey conducted by the Pan American Health Organization/World Health Organization (PAHO/WHO) indicates that the COVID-19 pandemic has disrupted diagnosis and treatment of viral hepatitis B and C infections in Latin America and the Caribbean, slowing progress on the goal of eliminating these infectious diseases by 2030.